Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, reported beneficial ownership of 1,386,343 shares of Sarepta Therapeutics, Inc. (SRPT) common stock each, equal to 1.31% of the class. The reported amount includes convertible notes representing 990,669 shares. Both entities reported shared voting and dispositive power over 1,386,343 shares.
Key Figures
Beneficial ownership:1,386,343 sharesPercent of class:1.31%Shares represented by convertible notes:990,669 shares
3 metrics
Beneficial ownership1,386,343 sharesReported by each of the two reporting entities
Percent of class1.31%Reported for each entity's beneficial ownership
Shares represented by convertible notes990,669 sharesIncluded in the reported beneficial ownership amount
Key Terms
beneficially owned, Convertible Notes, Shared Voting Power
3 terms
beneficially ownedregulatory
"Amount beneficially owned: 1,386,343"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
Shared Voting Powerregulatory
"Shared Voting Power 1,386,343"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many SRPT shares did AQR report beneficially owning?
Each reporting entity reported beneficial ownership of 1,386,343 shares, or 1.31% of the class. The reported amount includes convertible notes representing 990,669 shares.
Did AQR report sole or shared voting power over SRPT shares?
Each entity reported zero sole voting power and shared voting power over 1,386,343 shares. Each also reported zero sole dispositive power and shared dispositive power over 1,386,343 shares.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Sarepta Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
803607100
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
803607100
1
Names of Reporting Persons
AQR Capital Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,386,343.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,386,343.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,386,343.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.31 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
803607100
1
Names of Reporting Persons
AQR Capital Management Holdings, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,386,343.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,386,343.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,386,343.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.31 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Sarepta Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
215 FIRST STREET, SUITE 415, CAMBRIDGE, MASSACHUSETTS
02142
Item 2.
(a)
Name of person filing:
AQR Capital Management, LLC
AQR Capital Management Holdings, LLC
(b)
Address or principal business office or, if none, residence:
ONE GREENWICH PLAZA
SUITE 130
Greenwich, Connecticut
06830
(c)
Citizenship:
AQR Capital Management, LLC - UNITED STATES
AQR Capital Management Holdings, LLC - UNITED STATES
(d)
Title of class of securities:
Common Stock, $0.0001 par value per share
(e)
CUSIP No.:
803607100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
1,386,343
The reported amount includes Convertible Notes representing 990,669 shares of Common Stock, $0.0001 par value per share
(b)
Percent of class:
1.31 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
AQR Capital Management, LLC - 0
AQR Capital Management Holdings, LLC - 0
(ii) Shared power to vote or to direct the vote:
AQR Capital Management, LLC - 1,386,343
AQR Capital Management Holdings, LLC - 1,386,343
(iii) Sole power to dispose or to direct the disposition of:
AQR Capital Management, LLC - 0
AQR Capital Management Holdings, LLC - 0
(iv) Shared power to dispose or to direct the disposition of:
AQR Capital Management, LLC - 1,386,343
AQR Capital Management Holdings, LLC - 1,386,343
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Item 2(a) above.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
AQR Capital Management, LLC
Signature:
Henry Parkin
Name/Title:
Authorized Signatory
Date:
11/13/2026
AQR Capital Management Holdings, LLC
Signature:
Henry Parkin
Name/Title:
Authorized Signatory
Date:
11/13/2026
Exhibit Information
AQR Capital Management Holdings, LLC and AQR Capital Management, LLC hereby agree that this Schedule 13G is filed on behalf of each of the parties. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
